phrykt

Amgen (AMGN) net income: $7.7B

Amgen reported a net income of $7.7B for the year ended Dec 31, 2025, up 88.5% from $4.1B a year earlier.

From Amgen's filings with the SEC · Read the filing · AMGN stock page

Amgen net income by year

$5.9B2021$6.6B2022$6.7B2023$4.1B2024$7.7B2025

#54 of 3,748 US companies by net income · See the full ranking

Year endedNet incomeChange
Dec 31, 2025$7.7B+89%
Dec 31, 2024$4.1B-39%
Dec 31, 2023$6.7B+3%
Dec 31, 2022$6.6B+11%
Dec 31, 2021$5.9B–

Net income of similar companies

Companies in the same industry as Amgen, by SEC industry code, with the closest net income. Each name opens the same page for that company.

CompanyNet income, latest yearYear ended
Gilead Sciences$8.5BDec 31, 2025
Amgen$7.7BDec 31, 2025
Biogen$1.3BDec 31, 2025
Exelixis$783MJan 2, 2026
Neurocrine Biosciences$479MDec 31, 2025
Novavax$440MDec 31, 2025
Qiagen$425MDec 31, 2025

Questions and answers

What is Amgen's net income?

Amgen reported a net income of $7.7B for the year ended Dec 31, 2025, up 88.5% from $4.1B a year earlier.

Numbers as reported in Amgen's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology